Unspecified type of carcinoma in situ of left breast
ICD-10 D05.92 is a billable code used to indicate a diagnosis of unspecified type of carcinoma in situ of left breast.
Carcinoma in situ (CIS) of the breast refers to a group of abnormal cells that are found in the lining of the breast ducts or lobules. These cells have the potential to become invasive cancer but are currently confined to their original location. The unspecified type indicates that the specific histological subtype of carcinoma in situ has not been determined. Common types of breast carcinoma in situ include ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS). Patients diagnosed with D05.92 may undergo various surveillance protocols, including regular mammograms and clinical breast exams, to monitor for any signs of progression to invasive cancer. The risk of progression from carcinoma in situ to invasive breast cancer varies, with DCIS having a higher risk compared to LCIS. Factors influencing progression risk include tumor size, grade, and the presence of necrosis. Early detection and management are crucial in improving outcomes for patients with this diagnosis.
Pathology reports must clearly specify the type of carcinoma in situ and any relevant tumor characteristics.
Patients undergoing surgical excision or radiation therapy for DCIS.
Ensure that the treatment plan aligns with the documented diagnosis to avoid discrepancies.
Radiology reports should detail imaging findings and any recommendations for follow-up imaging.
Routine mammography screenings for patients with a history of carcinoma in situ.
Documentation must reflect the need for surveillance imaging based on the patient's risk profile.
Used for surgical treatment of DCIS.
Operative reports must detail the procedure performed and the diagnosis.
Oncology specialists should ensure that the diagnosis aligns with the surgical procedure.
Carcinoma in situ is significant because it indicates the presence of abnormal cells that have the potential to develop into invasive cancer if left untreated. Early detection and management are crucial for preventing progression.
